DOPAMINE HYDROCHLORIDE (dopamine hydrochloride) by Baxter is clinical pharmacology dopamine is a natural catecholamine formed by the decarboxylation of 3,4-dihydroxyphenylalanine (dopa). Approved for hemodynamic status in patients in shock. First approved in 1981.
Drug data last refreshed 3d ago · AI intelligence enriched 1w ago
Dopamine hydrochloride is a natural catecholamine injectable used to manage hemodynamic instability in patients experiencing shock. It works through dose-dependent activation of dopamine, beta-1, and alpha-1 adrenergic receptors, producing rapid inotropic and chronotropic cardiac effects within minutes of IV administration. The drug has a short plasma half-life of approximately 2 minutes, allowing for rapid titration and offset in acute care settings.
This is a mature, off-patent critical care product approaching end-of-life with limited commercial growth opportunities and likely small or consolidating brand teams focused on supply chain and hospital relationships.
CLINICAL PHARMACOLOGY Dopamine is a natural catecholamine formed by the decarboxylation of 3,4-dihydroxyphenylalanine (DOPA). It is a precursor to norepinephrine in noradrenergic nerves and is also a neurotransmitter in certain areas of the central nervous system, especially in the nigrostriatal…
Worked on DOPAMINE HYDROCHLORIDE at Baxter? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moJobs linked to dopamine hydrochloride are limited (0 tracked positions), reflecting the commodity nature of this critical care injectable. Career opportunities are concentrated in hospital relationship management, cost-based sales negotiations, and supply chain optimization rather than growth-oriented commercial roles. The LOE-approaching lifecycle signals job stability but limited advancement potential within this product line.